Arteris (NASDAQ:AIP) VP Sells $154,960.00 in Stock

Arteris, Inc. (NASDAQ:AIP) VP Paul Alpern sold 6,500 shares of the firm’s stock in a transaction on Thursday, October 1st. The shares were sold at an average price of $23.84, for a total transaction of $154,960.00. Following the transaction, the vice president directly owned 70,733 shares of the company’s stock, valued at $1,686,274.72. The trade was a 8.42% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Arteris Price Performance

Shares of NASDAQ:AIP opened at $23.40 on Thursday. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.57 and a current ratio of 1.57. Arteris, Inc. has a 52 week low of $12.06 and a 52 week high of $50.26. The firm has a market cap of $1.15 billion, a PE ratio of -26.90 and a beta of 1.90. The firm’s fifty day moving average is $24.57 and its 200-day moving average is $28.72.

Arteris (NASDAQ:AIP) last posted its quarterly earnings data on Thursday, August 6th. The company reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.06). The company had revenue of $24.13 million during the quarter, compared to analyst estimates of $23.48 million. Arteris had a negative net margin of 46.70% and a negative return on equity of 295.96%. Sell-side analysts predict that Arteris, Inc. will post -0.68 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the business. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in Arteris during the 2nd quarter valued at about $53,000. Versant Capital Management Inc grew its stake in Arteris by 33.7% in the 2nd quarter. Versant Capital Management Inc now owns 1,150 shares of the company’s stock valued at $56,000 after purchasing an additional 290 shares during the period. Royal Bank of Canada grew its position in Arteris by 366.7% during the first quarter. Royal Bank of Canada now owns 4,023 shares of the company’s stock valued at $66,000 after buying an additional 3,161 shares during the period. Allworth Financial LP purchased a new stake in shares of Arteris during the 2nd quarter worth approximately $87,000. Finally, State of Wyoming bought a new stake in shares of Arteris in the second quarter valued at $165,000. Institutional investors and hedge funds own 64.36% of the company’s stock.

Analysts Set New Price Targets

AIP has been the topic of several analyst reports. Roth Capital assumed coverage on Arteris in a report on Tuesday, August 4th. They issued a “buy” rating and a $40.00 target price on the stock. Rosenblatt Securities restated a “buy” rating and issued a $38.00 price target on shares of Arteris in a research report on Friday, August 7th. Craig Hallum started coverage on shares of Arteris in a research note on Monday, September 21st. They issued a “buy” rating and a $30.00 price objective on the stock. Weiss Ratings upgraded shares of Arteris from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, August 21st. Finally, Jefferies Financial Group raised shares of Arteris from a “hold” rating to a “buy” rating and lifted their target price for the stock from $35.00 to $50.00 in a research note on Friday, August 7th. Six analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $39.43.

Trending Headlines about Arteris

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Arteris secured an additional $3.3 million through the Trusted and Assured Microelectronics program to expand its third-party semiconductor IP security-assurance initiative with BAE Systems and SiFive. The program could strengthen Arteris’ position in secure chip design, government projects and advanced semiconductor supply chains. Arteris funding announcement
• Positive Sentiment: Oppenheimer maintained its Buy rating on Arteris, providing continued support from Wall Street despite recent selling pressure. Oppenheimer rating report
• Neutral Sentiment: CEO K. Charles Janac, COO Laurent Moll and VP Paul Alpern reported multiple sales of vested shares. Several transactions were made to cover tax-withholding obligations, making them a weaker signal of declining management confidence; however, the repeated executive selling may still weigh on short-term sentiment. Arteris insider trading report
• Negative Sentiment: Bayview Legacy LLC sold 100,000 shares for roughly $2.38 million. Because the filing did not identify tax withholding as the reason, the sale may raise concerns about additional stock supply and investor conviction. Bayview Legacy share sale
• Negative Sentiment: Arteris’ latest reported quarter included an adjusted loss of $0.10 per share, worse than the expected $0.04 loss. Although revenue exceeded forecasts, the company remains loss-making, with analysts expecting a full-year loss.

About Arteris

Arteris, Inc is a semiconductor intellectual property (IP) company that develops technologies used in the design of system-on-chip (SoC) devices. Its products help semiconductor and electronics companies connect, manage and protect the various processing, memory and other functional components integrated into complex chips.

The company’s portfolio includes network-on-chip (NoC) interconnect IP, which supports communication among different elements within an SoC, as well as cache-coherent interconnect, system IP and related design technologies.